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Abstract 
Background: Evidence is lacking for what defines post-intubation hypotension in the intensive care unit (ICU). 
If a valid definition could be used, the potential exists to evaluate possible risk factors and thereby improve post-
intubation. Thus, our objectives were to arrive at the best surrogate for post-intubation hypotension that accurately 
predicts both in-hospital and 90-day mortality in a population of ICU patients and to report mortality rates between 
the exposed and unexposed cohorts.
Methods: We conducted a retrospective cohort study of emergent endotracheal intubations in a medical-surgical 
ICU from January 1, 2010 to December 31, 2011 to evaluate surrogates for post-intubation hypotension that would 
predict in-hospital and 90-day mortality followed by an analysis of exposed versus unexposed using our best sur-
rogate. Patients were ≥18 years of age, underwent emergent intubation during their first ICU admission, and did not 
meet any of the surrogates 60 min pre-intubation.
Results: The six surrogates evaluated 60 min post-intubation were those with any systolic blood pressures 
≤90 mmHg, any mean arterial pressures ≤65 mmHg, reduction in median systolic blood pressures of ≥20 %, any 
vasopressor administration, any non-sinus rhythm and, fluid administration of ≥30 ml/kg. A total of 147 patients were 
included. Of the six surrogates, only the administration of any vasopressor 60 min post-intubation remained signifi-
cant for mortality. Twenty-nine patients were then labeled as hemodynamically unstable and compared to the 118 
patients labeled as hemodynamically stable. After adjusting for confounders, the hemodynamically unstable group 
had a significantly higher in-hospital and 90-day mortality [OR (95 % CI); 3.84 (1.31–11.57) (p value = 0.01) and 2.37 
(1.18–4.61) (p-value = 0.02)].
Conclusions: Emergently intubated patients manifesting hemodynamic instability after but not before intubation, as 
measured by vasoactive administration 60 min post-intubation, have a higher association with in-hospital and 90-day 
mortality.
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Background
Airway management using endotracheal intubation is 
one of the most important skills of the critical care phy-
sician. When performed non-emergently in a controlled 
setting such as the operating room, the complication rate 
of endotracheal intubation is relatively low; however, the 
complication rate increases when the procedure is per-
formed outside this controlled environment [1–4]. The 
incidence of adverse events increases even further when 
the airway has to be secured emergently [5–8]. The inci-
dence and outcomes of some adverse events related to 
emergent endotracheal intubation, including immediate 
airway-related complications, such as hypoxemia, aspira-
tion, airway injury and lost airway, have been described 
in detail in the literature [1–4, 9]. However, data on the 
hemodynamic perturbations after the intubation as well 
as their impact on patients’ outcomes is somewhat lim-
ited. Most of the current information on post-intubation 
hemodynamic instability comes from the emergency 
department [6, 8, 10, 11]. Studies based in the intensive 
care unit (ICU) setting found a relationship between 
post-intubation hemodynamic instability and increased 
morbidity and mortality; however, these studies failed to 
establish concrete definitions and validated predictors for 
mortality or increased length of stay [5, 7, 12].
Perhaps the most important data about post-intubation 
hemodynamic instability and its impact on patient out-
comes comes out of Canada. Green and colleagues per-
formed a structured retrospective chart review on all 
consecutive adult patients requiring emergent endotra-
cheal intubations over a 16-month period at a tertiary 
care emergency department [6]. Their consensus defini-
tion of hemodynamic instability was a decrease in sys-
tolic blood pressure (SBP) to ≤90 mmHg, a decrease 102 
in SBP of ≥20 % from baseline, a decrease in mean arte-
rial pressure (MAP) to ≤65 mm Hg, or the initiation of 
any vasopressor medication at any time in the 30 min fol-
lowing intubation. Out of the 218 patient charts that were 
reviewed, 96 (44 %) met their criteria of post-intubation 
hemodynamic instability but despite this high incidence, 
after controlling for baseline factors in multivariable 
analysis, the authors couldn’t show an association with 
increased mortality or hospital length-of-stay. The vaso-
pressors that were used in the study included epineph-
rine, norepinephrine, phenylephrine, and dopamine, but 
the authors didn’t compare the differences in outcome 
when a certain vasopressor was used. Although this study 
reviewed critically ill patients, the intubation took place 
in the emergency department and not in the ICU.
Given a possible association between post-intubation 
hypotension and increased ICU mortality/morbidity, 
lack of concrete definitions with which to define post-
intubation hypotension, and the inherent flaws in the 
aforementioned studies, more research on this topic is 
warranted. Thus, we conducted this retrospective cohort 
study in a population of mixed medical and surgical ICU 
patients with the primary aim of arriving at the best 
definition of hemodynamic instability that accurately 
predicts both in-hospital and 90-day mortality. Our sec-
ondary aim was to report in-hospital and 90-day mortal-
ity rates between those who became unstable, using our 
definition, versus those who did not.
Methods
The study was approved by Mayo Clinic Institutional 
Review Board for the use of existing medical records of 
patients who gave prior research authorization (reference 
number: 12-007113).
Study design
Retrospective cohort study of critical care patients 
admitted to a medical and surgical ICU, who underwent 
emergent intubation, during a 2-year period. This is a 
retrospective chart review of electronic medical records 
during the above period.
Study population
The population under study was obtained retrospectively 
from two critical care units at Mayo Clinic, Rochester, 
Minnesota. The two critical care units were a heteroge-
neous population of medical (65  %) and surgical (35  %) 
ICU patients admitted during the time period from Janu-
ary 1, 2010 to December 31, 2011. The 2-year time frame 
was chosen to limit variation in intubation practice as 
airway techniques (e.g., videolaryngoscopy), as well as 
resuscitation efforts (e.g., resuscitation protocols) have 
changed in previous years. The data included only those 
patients with first-time ICU admissions and excluded 101 
patients who did not provide prior research authoriza-
tion. The total cohort included 6714 consecutive patients 
admitted to the two intensive care units during the study 
interval. The cohort was further reduced to 2684 patients 
who received invasive mechanical ventilation on their 
first ICU admission during the same period excluding 
five patients due to age restriction (<18  years of age). 
Because of evidence suggesting higher mortality with 
repeated ICU admissions, we only included patients who 
had emergent endotracheal intubations on their first ICU 
admission [5, 13]. All emergent intubations analyzed in 
the current study were performed by trained critical care 
fellows.
Due to the number of data collection variables we 
wanted to explore, we utilized two electronic search 
algorithms for identifying both, if a patient had an emer-
gent endotracheal intubation and when this procedure 
took place. The electronic search algorithms on the 
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identification and timing of emergent intubations have 
been published elsewhere and we refer you to these 
sources [14, 15].
Using our previously validated electronic search algo-
rithms, we identified 484 patients as having received 
emergent endotracheal intubation on their first ICU 
admission. For data integrity, we manually reviewed 
all 484 charts. Upon manual review, we identified 333 
patients who definitely had received emergent endotra-
cheal intubation on their first ICU admission. Our elec-
tronic search algorithm captured an additional 151 charts 
as having received emergent endotracheal intubation. 
The additional capture was due to different electronic 
data systems at our institution where the electronic data 
pull stopped at one location (e.g., floor) and started to 
pull data at a different location (e.g., ICU). Therefore, the 
capture was identified at a time period when the patient 
was transitioning to the ICU but was endotracheally 
intubated just prior to ICU arrival because of respiratory 
distress on the floor. Therefore, our final cohort consisted 
of 333 patients. Please refer to Fig. 1 for a complete flow 
diagram of the process.
Surrogates evaluated for hemodynamic instability 
exposure
Based on the above literature review, we included six 
surrogate 171 markers for which we believe correctly 
identified all critically ill patients developing hemody-
namic compromise [5–12]. The six markers included 
(1) any SBP ≤90 mmHg 60 min post-intubation, (2) any 
MAP ≤65  mmHg 60  min post-intubation, (3) reduc-
tion in median SBP of ≥20  % 60  min post-intubation, 
(4) any vasopressor administration 60  min post-intuba-
tion, (5) any non-sinus rhythm 60  min post-intubation, 
and (6) fluid administration (crystalloid and/or colloid) 
of  ≥30  ml/kg 60  min post-intubation. In this study, all 
hemodynamic measurements were recorded from non-
invasive devices placed in the upper extremity by the ICU 
nurse with recordings every 1 min. Vasopressor adminis-
tration follows no formal protocol at our institution and 
is at the discretion of the treating clinician.
Retrospective cohort study with outcome assessment
We choose to focus on two outcome variables, in-hos-
pital and 90-day mortality. We felt that 90-day mortality 
was an important outcome metric to evaluate in addi-
tion to in-hospital mortality as some of the exposures 
under study (e.g., fluid accumulation) may contribute to 
increased short-term mortality [16]. Ninety day mortal-
ity was measured through the electronic medical record 
as “alive or deceased”. This was sufficient as all patients in 
the current study receive care at Mayo Clinic Rochester 
and we only had 13 subjects lost to follow-up.
Using in-hospital and 90-day mortality as the outcome 
variable, a univariate model was constructed for each 
surrogate marker of hemodynamic instability separately. 
The surrogate marker(s) that were significant at a p-value 
of ≤0.05 in the univariate model were carried over to the 
multivariate model.
In the multivariate model, we choose to focus on three 
possible confounders─age, sepsis as primary diagnosis, 
and APACHE III score calculated 24 h from ICU admis-
sion. We recognize that there are other possible con-
founders, but we did not want to over-fit our final model 
given the number of events (death) for in-hospital and 
90-day mortality.
We accepted predictors in the final model with a 
p-value of  ≤0.05. The above process of constructing 
the model with each surrogate marker separately was 
repeated for the multivariate model, with the addition 
of the confounders. Using the results from the analysis, 
we separated the cohort into exposed and unexposed by 
using surrogate marker(s) of hemodynamic instability 
that best predicted in-hospital and 90-day mortality.
For the analyses, all information was collected via pas-
sive methods with the use of electronic medical records. 
The data was captured from the Mayo Clinic ICU Data 
mart. This electronic medical record is reliable and vali-
dated. The details of which have been published else-
where [17]. Four clinicians (BR, CH, LJ, and SA) manually 
abstracted the electronic medical record of all 333 charts 
for each of the exposures and were kept blinded to the 
outcome of interest, mortality. The four clinicians fol-
lowed a standard operating manual for data collection 
and were trained in its use through the use of practice 
charts prior to data collection. Inter-rater agreement 
(kappa) was not assessed. However, charts flagged by 
data abstractors who were unsure of data collection were 
then later confirmed by a third party (O.D.). The outcome 
was assessed by two critical care physicians (NJS and RK) 
who were unaware of the exposure status of subjects.
Statistical analysis
Continuous measurements are expressed as 
mean  ±  standard deviation (SD) or median and inter-
quartile (IQR) where appropriate, and were compared for 
statistical differences using paired t-tests or Mann–Whit-
ney U tests. Categorical variables are reported as counts 
and percentages and were tested for significance using 
Chi square or Fisher’s exact tests when applicable. All 
prognostic surrogates that had a p-value of ≤0.05 deter-
mined by the univariate regression model were entered 
into a multivariate logistic regression model using age, 
APACHE III score, and sepsis diagnosis as covariates. 
None of these covariates showed significant collinear-
ity between each other or the surrogate definition used 
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(101 patients - no research approval)
(3,924 patients - ICU readmission and non-
ventilated)
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(147 patients - no hemodynamic
instability 60 minutes prior to
intubation)
Excluded
(186 patients - hemodynamic instability 60
minutes prior to intubation)
Hemodynamic instability surrogates (60 minutes
before intubation)
1) Any systolic blood pressure ≤ 90 mmHg
2) Any mean arterial pressure ≤ 65 mmHg
3) Median systolic blood pressure 20% drop
4) Any vasopressor initiation
5) Any non-sinus rhythm
6) Any fluid bolus ≥ 30 ml/kg
Fig. 1 Flow-diagram for the inclusion and exclusion of study patients
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(variance inflation factor <5.0). In-hospital mortality 
served as the dependent variable and the model was per-
formed by the means of a stepwise backward procedure. 
Patients who met our best definition of instability were 
then compared with those who did not meet this defini-
tion. Ninety day mortality was then evaluated with Cox 
proportional hazards using the process above. Thirteen 
subjects were lost to follow-up. Proportional hazards 
assumption was evaluated by Schoenfeld residuals for 
age, APACHE III, sepsis diagnosis and vasopressor use, 
and there was no evidence suggesting that proportional 
hazards assumption was violated. Model fit was calcu-
lated using Harrell’s c-index [18]. The c-index for the 
model was 0.74 [95  % CI (0.67–0.80)]. Odds ratios and 
hazard ratios are presented with 95  % confidence inter-
vals. All reported p-values are two-tailed, and a value 
≤0.05 was considered statistically significant. We used 
SAS version 9.3 and JMP version 9.0 (SAS Institute Inc, 
Cary, NC, USA) statistical packages for all calculations.
Results
The final cohort consisted of 147 patients who were in 
need of emergent endotracheal intubation during their 
first ICU admission after excluding 186 patients who 
met any of the aforementioned surrogates. The demo-
graphic and clinical characteristics of total study subjects 
as well as the subsets of stable (unexposed) and unsta-
ble (exposed) patients are shown in Additional file  1: 
Table S1.
For in-hospital mortality, we included all six surrogate 
markers separately in the univariate model. Significant 
markers which had an association with in-hospital mor-
tality included initiation of any vasopressor 60 min post-
intubation (p-value  =  0.01) and any MAP  ≤65  mmHg 
60  min post-intubation (p-value  =  0.02). We then per-
formed a multivariate analysis using three potential con-
founders of age, sepsis diagnosis, and APACHE III score 
24 h from ICU admission with vasopressor and MAP sur-
rogates separately. Initiation of any vasopressor 60  min 
post-intubation remained significant (p-value  =  0.01); 
however, the marker of any MAP ≤65  mmHg 60  min 
post-intubation did not (p-value = 0.10).
For 90-day mortality, we repeated the above process 
for all six surrogate markers in the univariate model 
using Cox proportional hazards. Significant markers 
which had an association with 90-day mortality included 
initiation of any vasopressor 60  min post-intubation 
(p-value  =  0.02), any MAP ≤65  mmHg 60  min post-
intubation (p-value =  0.03), and fluid administration of 
≥30 ml/kg 60 min post-intubation (p-value = 0.04). We 
then performed a multivariate analysis using the same 
three confounders as outlined above for all three sur-
rogates separately. Initiation of any vasopressor 60  min 
post-intubation remained significant (p-value = 0.02) but 
fluid administration of ≥30  ml/kg (p-value =  0.11) and 
any MAP ≤65  mmHg 60  min post-intubation did not 
(p-value = 0.24). Refer to Additional file 2: Table S2 and 
Additional file 3: Table S3 for univariate and multivariate 
model selection.
Based on the above analyses, one surrogate marker 
was chosen for hemodynamic instability post-intuba-
tion that predicted both in-hospital and 90-day mortal-
ity; any vasopressor initiation 60  min post-intubation. 
Of the 147 analyzable patients, 29 met the criteria of 
any vasopressor 60  min post-intubation. However, only 
three patients had vasopressor initiation without any 
documented MAP ≤65  mmHg, and 14 had vasopres-
sor initiation without fluid administration ≥30  ml/
kg 60  min post-intubation. Thirty patients had the out-
come (death) upon hospital discharge from the time of 
first ICU admission. Of those 30 patients, 11 had vaso-
pressors started 60  min after intubation as compared 
to 19 who did not have any vasopressors started 60 min 
after intubation. Patients found to have any vasopres-
sor administered 60 min post-intubation, using this as a 
marker for hemodynamic instability, had a significantly 
higher in-hospital mortality (38 vs. 16 %, p-value = 0.01). 
After adjusting for age, sepsis diagnosis, and APACHE 
III score, these patients were more likely to die, OR (95 % 
CI)  =  3.84 (1.31–11.57) (p-value  =  0.01) (Additional 
file  4: Table  S4). Using Cox proportional hazards for 
90-day mortality, 42 patients had the outcome (death) at 
90 days from the time of first ICU admission. Of the 42 
patients, 14 patients had any vasopressor initiated 60 min 
post-intubation versus 28 who did not have any vaso-
pressor 60  min post-intubation. Patients found to have 
been exposed to this surrogate marker of hemodynamic 
instability had a significantly higher 90-day mortality (48 
vs. 24 %, p-value = 0.02) (Fig. 2). After adjusting for age, 
sepsis diagnosis, and APACHE III score, these patients 
were more likely to die, OR (95 % CI) = 2.37 (1.18–4.61) 
(p-value = 0.02) (Additional file 4: Table S4). Moreover, 
hospital length-of-stay was significantly longer in those 
who were exposed to this surrogate marker of hemody-
namic instability (Additional file 1: Table S1).
Other potential factors that may be associated with 
post-intubation hemodynamic instability such as choice 
of sedative/hypnotic agent administered, pre-existing 
hypoxemia or hypovolemia and, use of pre-intubation 
non-invasive ventilation were evaluated and found not to 
be significantly different between the two groups (Addi-
tional file 1: Table S1).
Analyzing the vasopressor group revealed that only 5 
of 29 patients required norepinephrine when exposed to 
a vasopressor 60 min post-intubation as compared to 27 
who required phenylephrine. Three of the five patients 
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requiring norepinephrine also required phenylephrine. 
All 10 deaths came from patients receiving only phenyle-
phrine as the vasopressor of choice. Patients who sur-
vived had a median dose of phenylephrine of 300  mcg 
(187.5–825 mcg) versus 200 mcg (100–1500 mcg) among 
those who died.
For predicting in-hospital mortality, the model with 
age, APACHE III score, sepsis diagnosis, and vasopressor 
exposure 60 min post-intubation (hemodynamic instabil-
ity) had an area under the curve of 0.80.
Discussion
We set out to find the best surrogate marker of hemo-
dynamic instability that would accurately predict both 
in-hospital and 90-day mortality. For both outcomes, 
only initiation of any vasopressor was significantly asso-
ciated with in-hospital and 90-day mortality even after 
adjustment for age, APACHE III score, and sepsis diag-
nosis. In contrast to studies using different indicators 
for post-intubation hemodynamic compromise such as 
SBP ≤90  mmHg and reporting poor outcomes, we did 
not find significant associations with these commonly 
reported markers and mortality. Moreover, we included 
parameters not previously used in the literature and were 
unable to find associations with these additional factors 
and mortality.
Our results are consistent with reports of vasoac-
tive exposure and mortality in the critical care environ-
ment. For example, Dunser et al. demonstrated that the 
mean vasopressor load, which included norepineph-
rine, dopamine, epinephrine, dobutamine, and phenyle-
phrine, was associated with mortality (relative risk 1.83) 
and adverse events [19]. Furthermore, literature exists 
for individual vasoactive agents such as dopamine and 
vasopressin and increased mortality in septic patients 
and trauma patients [20, 21]. These findings are reported 
largely in septic patients. However, our study demon-
strates the opposite. In the present study, patients that 
had a favorable outcome included a large proportion 
of septic patients as compared to the group which had 
an unfavorable outcome. The finding of very few sepsis 
patients with increased mortality may represent early 
recognition and treatment of the disease versus those 
not labeled with this diagnosis. At our institution, acti-
vation alerts for sepsis protocols notify providers early 
on of potential sepsis patients. These activation alerts 
are designed to provide care that is consistent with cur-
rent sepsis guidelines. Therefore, it may be that patients 
not labeled with this diagnosis upon admission may not 
receive interventions (e.g. fluid optimization) that would 
prevent exposure to vasoactive agents for post-intubation 
hemodynamic instability leading to increased mortality. 
Even though there was no statistical difference in crys-
talloid and/or colloid volume during the interval of 24 h 
pre- and post-intubation between the groups, the hemo-
dynamically stable group (unexposed) had more fluid 
administration 24  h pre-intubation as compared to the 
hemodynamically unstable group (exposed) (Additional 
file  1: Table  S1). Although the theory is speculation on 
the authors’ part, this finding warrants further research 
to identify the factors that lead to vasoactive exposure 
post-intubation.
The current study has several limitations. First, the 
surrogate markers evaluated may not be all inclusive. 
The markers explored in this study go above and beyond 
those used in the literature. Therefore, we feel our inclu-
sion criteria were sensitive enough to capture all hemo-
dynamically unstable patients in our ICU. Second, the 
surrogate markers explored were not mutually exclu-
sive. The reason being is that patients with vasoactive 
administration are more likely than not to have a MAP 
≤65 mmHg at the time of vasoactive administration. This 
was indeed noted in our population of analyzable study 
subjects. Therefore, we felt it was not beneficial to have 
mutually exclusive factors. Third, we cannot exclude the 
possibility of referral bias in our sample as patients who 
present to Mayo Clinic may have higher levels of severity 
than other settings. Fourth, our sample size was limited 
for some of the above analyses as shown by the wide con-
fidence intervals obtained. In addition, with a larger sam-
ple size, we may have seen the other potential explored 
hemodynamic definitions reach statistical significance. 
Fifth, our results may not be generalizable to specialized 
critical care patients such as trauma, pediatrics or neuro 
critical care patients as these patients were absent from 
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Fig. 2 90-day survival curves between those labeled as hemo-
dynamically stable (unexposed) and those labeled as unstable 
(exposed). Surrogate marker of hemodynamic status: no vasopressor 
60 min post-intubation (stable) vs. any vasopressor 60 min post-
intubation (unstable)
Page 7 of 8Smischney et al. BMC Res Notes  (2015) 8:445 
our analysis. Lastly, although we did evaluate potential 
confounders such as co-morbidities, induction agents, 
fluid administration, we acknowledge there are other 
confounders that may have been missed (e.g., correct 
non-invasive device used, location of measurement, etc.) 
and thus, the results should be interpreted with caution.
Conclusions
We have demonstrated that exposure to any vasopres-
sor 60 min post-intubation, as a marker of hemodynamic 
instability, is associated with increased in-hospital and 
90-day mortality in those that are hemodynamically 
stable prior to intubation. This effect remained despite 
adjustments in the analyses for potential confound-
ers. The novelty of the present study is the association 
of vasopressor requirement 60  min post-intubation and 
90-day mortality, which to the authors’ knowledge, has 
not been demonstrated prior. In addition, we have dem-
onstrated that the use of a standard definition for post-
intubation hypotension such as SBP <90  mmHg, while 
may be of value in other settings (i.e., emergence depart-
ment), was not useful in our analysis. Thus, factors that 
were relevant in predicting hemodynamic instability sur-
rounding endotracheal intubations in non-ICU settings 
may not be relevant when analyzing ICU patients. Fur-
ther research is needed to validate our findings prospec-
tively and to define potential modifiable risk factors that 
may lead to the requirement of vasoactive medication 
administration 60 min post-intubation for hemodynamic 
failure.
Abbreviations
APACHE: acute physiology and chronic health evaluation; ICU: intensive care 
unit; MAP: mean arterial pressure; OR: odds ratio; SBP: systolic blood pressure.
Authors’ contributions
NJS conceived the study idea/design, performed a literature review, per-
formed data analysis with data interpretation, and made final contributions 
to the writing and intellectual content of the manuscript. OD performed a 
literature review, made final contributions to the writing and intellectual con-
tent of the manuscript with data collection as needed. BDR, CCH, LMJ, and SA 
Additional files
Additional file 1: Table S1. Sample characteristics grouped by surrogate 
marker for hemodynamic status post-intubation.
Additional file 2: Table S2. Univariate model demonstrating predictive 
capability of all six surrogate markers of hemodynamic instability for in-
hospital and 90-day mortality.
Additional file 3: Table S3. Multivariate model demonstrating predictive 
capability of selected surrogates from univariate model for in-hospital and 
90-day mortality after adjusting for age, sepsis diagnosis, and APACHE III 
score.
Additional file 4: Table S4. Comparison of in-hospital and 90-day 
mortality between those patients labeled as hemodynamically stable 
(unexposed) and those labeled as hemodynamically unstable (exposed).
performed data collection. RK performed data analysis with data interpreta-
tion. All authors read and approved the final manuscript.
Author details
1 Department of Anesthesiology, Mayo Clinic, 200 First St SW, Rochester, MN 
55905, USA. 2 Multidisciplinary Epidemiology and Translational Research 




Compliance with ethical guidelines
Competing interests
The authors declare that they have no competing interests.
Financial support and disclosure
This work was supported by the Division of Critical Care Medicine with no 
direct financial support.
Ethics
The study was approved by Mayo Clinic Institutional Review Board for the use 
of existing medical records of patients who gave prior research authorization. 
Reference number: 12-007113.
Received: 17 November 2014   Accepted: 7 September 2015
References
 1. Caplan RA, Posner KL, Ward RJ, Cheney FW. Adverse respiratory events in 
anesthesia: a closed claims analysis. Anesthesiology. 1990;72:828–33.
 2. Cheney FW, Posner KL, Caplan RA. Adverse respiratory events infrequently 
leading to malpractice suits. A closed claims analysis. Anesthesiology. 
1991;75:932–9.
 3. Domino KB, Posner KL, Caplan RA, Cheney FW. Airway injury during 
anesthesia: a closed claims analysis. Anesthesiology. 1999;91:1703–11.
 4. Metzner J, Posner KL, Domino KB. The risk and safety of anesthesia at 
remote locations: the US closed claims analysis. Curr Opin Anaesthesiol. 
2009;22:502–8.
 5. Jaber S, Amraoui J, Lefrant JY, Arich C, Cohendy R, Landreau L, Calvet 
Y, Capdevila X, Mahamat A, Eledjam JJ. Clinical practice and risk fac-
tors for immediate complications of endotracheal intubation in the 
intensive care unit: a prospective, multiple-center study. Crit Care Med. 
2006;34:2355–61.
 6. Green RS, Edwards J, Sabri E, Fergusson D. Evaluation of the incidence, 
risk factors, and impact on patient outcomes of postintubation hemody-
namic instability. CJEM. 2012;14:74–82.
 7. Schwartz DE, Matthay MA, Cohen NH. Death and other complica-
tions of emergency airway management in critically ill adults. A 
prospective investigation of 297 tracheal intubations. Anesthesiology. 
1995;82:367–76.
 8. Heffner AC, Swords D, Kline JA, Jones AE. The frequency and significance 
of postintubation hypotension during emergency airway management. J 
Crit Care. 2012;27(417):e9–13.
 9. Mort TC. Complications of emergency tracheal intubation: immediate air-
way-related consequences: part II. J Intensive Care Med. 2007;22:208–15.
 10. Green R, Hutton B, Lorette J, Bleskie D, McIntyre L, Fergusson D. Incidence 
of postintubation hemodynamic instability associated with emergent 
intubations performed outside the operating room: a systematic review. 
CJEM. 2014;16:69–79.
 11. Heffner AC, Swords DS, Nussbaum ML, Kline JA, Jones AE. Predictors 
of the complication of postintubation hypotension during emergency 
airway management. J Crit Care. 2012;27:587–93.
 12. Dennis CJ, Chung KK, Holland SR, Yoon BS, Milligan DJ, Nitzschke SL, 
Maani CV, Hansen JJ, Aden JK, Renz EM. Risk factors for hypotension in 
urgently intubated burn patients. Burns. 2012;38:1181–5.
Page 8 of 8Smischney et al. BMC Res Notes  (2015) 8:445 
 13. Rosenberg AL, Watts C. Patient readmitted to the 472 ICUs*: a systematic 
review of risk factors and outcomes. Chest. 2000;118:492–502.
 14. Smischney NJ, Velagapudi VM, Onigkeit JA, Pickering BW, Herasevich V, 
Kashyap R. Retrospective derivation and validation of a search algorithm 
to identify emergent endotracheal intubations in the intensive care unit. 
Appl Clin Inform. 2013;4:419–27.
 15. Smischney NJ, Velagapudi VM, Onigkeit JA, Pickering BW, Herasevich V, 
Kashyap R. Retrospective derivation and validation of a search algorithm 
to identify mechanical ventilation initiation in the intensive care unit. 
BMC Med Inform Decis Mak. 2014;14:55.
 16. Vaara ST, Korhonen AM, Kaukonen KM, Nisula S, Inkinen O, Hoppu S, Lau-
rila JJ, Mildh L, Reinikainen M, Lund V, Parviainen I, Pettilä V. The FINNAKI 
study group: fluid overload is associated with an increased risk for 90-day 
mortality in critically ill patients with renal replacement therapy: data 
from the prospective FINNAKI study. Crit Care. 2012;16:R197.
 17. Herasevich V, Pickering BW, Dong Y, Peters SG, Gajic O. Informatics 
infrastructure for syndrome surveillance, decision support, reporting, and 
modeling of critical illness. Mayo Clin Proc. 2010;85:247–54.
 18. Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of 
medical tests. JAMA. 1982;247:2543–6.
 19. Dünser MW, Ruokonen E, Pettilä V, Ulmer H, Torgersen C, Schmittinger CA, 
Jakob S, Takala J. Association of arterial blood pressure and vasopressor 
load with septic shock mortality: a post hoc analysis of a multicenter trial. 
Crit Care. 2009;13:R181.
 20. Boulain T, Runge I, Bercault N, Benzekri-Lefevre D, Wolf M, Fleury C. Dopa-
mine therapy in septic shock: detrimental effect on survival? J Crit Care. 
2009;24:575–82.
 21. Collier B, Dossett L, Mann M, Cotton B, Guillamondegui O, Diaz J, Flem-
ing S, May A, Morris J. Vasopressin use is associated with death in acute 
trauma patients with shock. J Crit Care. 2010;25:173.e9–14.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
